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Aims: The Michigan Incontinence Symptom Index (M-ISI) is a validated measure for urinary incontinence. This study
evaluates the M-ISI as a screening tool for clinically relevant urinary incontinence in a population-based sample of
women. Methods: The Establishing the Prevalence of Incontinence (EPI) Study is a case-control, population-based
study that enrolled women ages 35–64, with and without urinary incontinence. The M-ISI is a validated questionnaire
with subdomains for stress and urgency urinary incontinence. Two hundred fourteen EPI subjects underwent a clinical
evaluation and urodynamic testing to establish the presence and type of urinary incontinence, and also completed the
M-ISI. The M-ISI scores were evaluated using receiver operating characteristic (ROC) curves to determine the optimal
diagnostic threshold scores above which women were likely to have clinically relevant urinary incontinence.
Results: The optimal M-ISI diagnostic threshold scores were determined to be 3 for the stress urinary incontinence
subdomain (area under the curve of 0.79), 5 for the urgency urinary incontinence subdomain (area under the curve of
0.88), and 7 for the Total M-ISI score (area under the curve of 0.89). The sensitivity and specificity of the M-ISI
questionnaire for stress, urgency, and total urinary incontinence were 77% and 73%, 86% and 76%, and 84% and 75%,
respectively. Conclusions: The M-ISI may be used to screen for clinically relevant urinary incontinence with high
sensitivity and specificity amongwomen ages 35–64. A brief, self-administered tool such as theM-ISI can help health care
providers identify and manage women with urinary incontinence. Neurourol. Urodynam. 34:332–335, 2015.
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INTRODUCTION
Urinary incontinence is a common condition that affects up
to 40% of community-dwelling women in the United States.1
Incontinence significantly impacts the social interactions,
interpersonal and sexual relationships, careers, psychological
well-being, and quality of life of women with this condition.2
Despite the availability of behavioral, medical, and surgical
treatment options, only aminority ofwomen actually seek care
for this condition.3–6
Since few women seek care for their urinary incontinence
symptoms, primary care physicians can play a key role in
identifying women whomay benefit from treatment.7 Howev-
er, primary care providers seeking to identify patients with
urinary incontinence face several challenges, including a lack of
diagnostic tools, time constraints, and a need to determine
whether urinary incontinence is clinically relevant.8 For these
reasons, a validated tool that can quickly identify women with
clinically relevant urinary incontinence should be of value in
the primary care setting.
The Michigan Incontinence Symptom Index (M-ISI) is a
validated questionnaire that assesses type of urinary inconti-
nence (stress versus urgency) and quantifies the severity and
bother of the incontinence. It is a parsimonious measure that is
simple for the individual to complete, and can be used both as a
clinical aid to facilitate delivery of care and as a research tool to
help quantify and standardize urinary outcome measure-
ments.9 Using a population-based sample of women from the
Establishing the Prevalence of Incontinence (EPI) Study, we
identified threshold scores for the M-ISI that could be used to
screen for clinically relevant urinary incontinence. This tool can
be used in the primary care setting to aid in the identification of
women with urinary incontinence and can help to guide
management and referral of these patients for optimal
treatment.
MATERIALS AND METHODS
Subjects
EPI Study recruited community-dwelling women ages 35–64
residing in three southeasternMichigan communities between
2002 and 2004. Women were contacted via telephone calls
made to numbers purchased from a commercial survey-
sampling firm.10 A total of 2,814 women completed the
telephone interview, and a subset of these women underwent
urodynamic and clinical evaluation. These cohorts were
selected to include women both with and without urinary
incontinence.
Details of the clinical evaluation conducted in the EPI Study
have been published. The subset of the larger cohort that was
invited to come in for urodynamic and clinical evaluation were
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selected based on a priori sample size calculations to include
50–65 black and white women in each continence category
(continent, SUI, UUI).11 When the selected women presented to
the clinic, each subject was asked at the time of her entry into
the study whether or not she had urinary incontinence. A
physician interviewed each woman (prior to clinical testing
and the physical exam) and recorded whether or not the
physician thought that the patient had urinary incontinence,
and if so, the type of incontinence (stress, urgency, or both). The
physician then performed a clinical evaluation, including a
POP-Q pelvic exam, vaginal examwith palpation of the levator
muscles, Q-tip angle test, measurement of bladder post-void
residual volume, urodynamics with urethral pressure profile,
leak point pressure and uroflow, and a paper towel test. At the
end of the clinical visit, the physician reviewed both the
findings from the patient’s self-report and the objective clinical
data to render a final diagnosis of the presence and type of
urinary incontinence, exclusive of the M-ISI.11
Michigan Incontinence Symptom Index (M-ISI)
The M-ISI was developed using psychometric principles and
has proven reliability and validity. It is a 10-itemmeasure that
consists of a Total M-ISI domain (sum of items 1–8) and a
distinct Bother domain (sum of items 9–10). The Total M-ISI
score consists of three subdomains (items 1–3 for Stress Urinary
Incontinence [SUI], items 4–6 for Urgency Urinary Incontinence
[UUI], and items 7–8 for Pad Use [PU]). All 10 items have
Likert scale response options (range 0–4), with higher values
representing greater symptoms and greater bother. The Total
M-ISI domain ranges from scores of 0 to 32, the Bother domain
ranges from scores of 0 to 8, the SUI and UUI subdomains range
from scores of 0 to 12, and the PU subdomain ranges from scores
of 0 to 8. The overall domains and subdomains are scored
by simply adding up their respective subdomains. The
minimally important difference (MID) has been determined
for the following domains/subdomains: Total M-ISI (4 points),
SUI subdomain (2 points), UUI subdomain (2 points), and PU
subdomain (1 point).9
Statistical Methods
Continuous variables were summarized as means with
standard deviations, and categorical variables were summa-
rized as percentages. Receiver operating characteristic (ROC)
curves were constructed for the SUI subdomain score, the UUI
subdomain score, and the Total M-ISI domain score. These
curves were then used to identify the inflection points that
would optimize the sensitivity and specificity for each
subdomain and domain.
The endpoints used to model the ROC curve for SUI required
the presence of all of the following criteria: (i) the patient’s self-
reported presence of incontinence, ensuring that the leakage of
urine was noticeable to the patient, (ii) demonstrable SUI on
urodynamics, and (iii) the physician’s final interpretation that
the patient had SUI, based on the physician’s review of the
entire clinical encounter. In light of recent reports that
urodynamics are not a necessary component to the workup
of uncomplicated SUI in women12 and the possibility that
urodynamics may fail to demonstrate SUI in a women with
these symptoms,13 we performed a sensitivity analysis using a
modified definition of SUI where leakage of urine with either
cough or valsalva on physical exam substituted for the presence
of SUI on urodynamics.
For our definition of UUI, which is only demonstrable on
urodynamics in approximately 50% of patients with this
condition,14 urodynamic testing results were not included as
part of the criteria used to define UUI. Therefore, the ROC curve
for the UUI subdomain included only (i) the patient’s self-
reported presence of incontinence, and (ii) the physician’s final
diagnosis of UUI. The presence of either UUI or SUI, as defined
above, was then used as the definition of clinically relevant
urinary incontinence for the purpose of this study. Positive and
negative predictive values were calculated for each subdomain
and for the total M-ISI domain score. These potential threshold
scores were then evaluated by a group of urologists and
urogynecologists (AMS, JTW, DMM, JOLD) for face validity.
Statistical analyses were conducted using SAS version 9.2
software (SAS Institute, Cary, NC).
RESULTS
A total of 394 women from the EPI population came to the
clinic for evaluation. Of this cohort, 214 consecutive women
completed both the clinical evaluation and theM-ISI (due to the
late introduction of the M-ISI into the study). The demographic
data and pertinent health history of these subjects are shown
in Table I. Their mean age was 50.5 years, mean parity was
2.2, and mean BMI was 33.1. Of the 214 women, a total of 102
(47.7%) had a final diagnosis of urinary incontinence (of any
type), 43 (20.1%) had a final diagnosis of SUI, and 90 (42.1%) had
a final diagnosis of UUI. Since the presence of stress and
urgency urinary incontinencewere notmutually exclusive, any
given subject could have a diagnosis of stress, urgency, or both
stress and urgency urinary incontinence.
The ROC curves for the SUI subdomain, the UUI subdomain,
and the Total M-ISI domain are shown in Figure 1, with
corresponding areas under the curves of 0.79 (95% CI: 0.71,
0.86), 0.88 (95% CI: 0.83, 0.92), and 0.88 (95% CI: 0.83, 0.92),
respectively. Table II presents the optimal threshold scores for
each subdomain and domain, with their corresponding sensitivi-
ty, specificity, positive predictive value and negative predictive
TABLE I. Subject Demographic Characteristics and Pertinent Health History
Estimate
Demographic factors
Age in years (mean, SD) 50.5 (8.6)
Parity (mean, SD) 2.2 (1.7)
BMI (mean, SD) 33.1 (8.6)
Race (%)
White 31.8
Black 68.2
Education (%)
No high school degree 3.3
High school degree, but no college degree 18.2
4 years college degree, but no postgraduate degree 60.8
Any post graduate study 17.8
Total household income (%)
<$20,000 14.0
$20,000–$39,000 16.8
$40,000–$59,000 7.5
$60,000–$100,000 18.7
$100,000þ 43.0
Currently employed (%) 63.1
Pertinent health history
Have not had a menstrual period in the last year (%) 57.0
On estrogen replacement (%) 14.0
Self-reported incontinence (%) 54.0
Using pads (%) 53.2
Final diagnosis of urinary incontinence (any type, %) 47.7
Final diagnosis of stress urinary incontinence (%) 20.1
Final diagnosis of urge urinary incontinence (%) 42.1
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value. The SUI subdomain threshold score of3 has a sensitivity
of 77%, specificity of 73%, positive predictive value of 43%, and a
negative predictive value of 92%. The UUI subdomain threshold
score of 5 has a sensitivity of 86%, specificity of 76%, positive
predictive value of 73%, andnegative predictive value of 86%. The
TotalM-ISI domain threshold score of7 has a sensitivity of 84%,
specificity of 75%, positive predictive value of 75%, and negative
predictive value of 84%.
Results from the sensitivity analysis for our SUI definition,
where we substituted positive findings of leakage of urine on
physical exam (with cough or valsalva) for the presence of SUI
on urodynamics, yielded similar results with a screening
threshold of 3, a sensitivity and specificity of 74% and 71%,
and an area under the curve of 0.76 (95% CI: 0.68, 0.84).
DISCUSSION
A minority of women seek care for symptoms of urinary
incontinence due to feelings of embarrassment, lack of
knowledge about available treatment options, and dismissing
their symptoms as being either too trivial or as a normal part of
ageing.6 A screening tool for urinary incontinence in the
primary care population, such as the M-ISI, would greatly
enhance the identification of women would benefit from
treatment. This study identified clinically relevant threshold
scores for the M-ISI to establish its use as a screening tool for
urinary incontinence in the general population. Threshold
scores were determined to be3 for the SUI subdomain,5 for
the UUI subdomain, and 7 for the Total M-ISI domain. The
threshold scores also exceed the minimally important differ-
ence for each subdomain and domain of the M-ISI. The
minimally important difference (MID) is the smallest difference
in the score that patients perceive as beneficial.15 The MIDs for
the SUI and UUI subdomains are each 2 points, and the MID for
the TotalM-ISI is 4 points.9 Each of the threshold scores is higher
than their corresponding MIDs, further supporting the validity
of these reflex cut-offs. These values can be used to guide
physicians in deciding which women might benefit from
further diagnostic evaluation, treatment, and potential referral
for urinary incontinence.
Our study focused on screening threshold scores for SUI and
UUI, but not for mixed urinary incontinence as SUI and UUI
severity are the clinically relevant concepts when it comes to
practice. While the presence of both components may be
qualitatively described asmixed urinary incontinence, referrals
are likely when at least one of these components is severe
enough rather thanmerely havingmixed urinary incontinence.
Moreover, there is no single therapy for mixed urinary
incontinence, so we rely on clinical expertise to determine
which component to address first when both are present. Such
nuanced guidance on therapy is clearly beyond the primary
care setting but theMISI ratio, previously published,9 does offer
an ability to determine if in incontinence is stress or urge
predominant.
Other measures have been developed for use as screening
tools for urinary incontinence. None of these other tools,
however, combines the use of a population-based sample of
women with the scope of the M-ISI to determine the type,
severity, and bother of urinary incontinence. One of these other
measures is the 3 Incontinence Questions (3IQ). The 3IQ has
comparable sensitivities and specificities to the M-ISI, but it
was developed to discern the type (urgency vs. stress), not the
presence, of urinary incontinence. Additionally, the 3IQ was
developed in a cohort of patients who all had clinically
bothersome urinary incontinence (defined as three or more
episodes of incontinence per week for at least 3 months, and
symptoms thatwere bothersome enough for the patient to seek
treatment),16 making its use only meaningful in similar
populations and not in the community at large.
Another measure, the Sandvik–Hunskaar, is a two-item
questionnaire17 that was validated in a primary health care
setting to have a sensitivity and specificity of 66% and 88% for
stress urinary incontinence, and 56% and 96% for urgency
urinary incontinence. This questionnaire has been used in
epidemiological surveys, but it is limited as a screening tool by
its low sensitivities and its lack of information about the bother
caused by urinary incontinence.18
Fig. 1. Receiver operating characteristic (ROC) curves for the (A) stress urinary incontinence subdomain, (B) urgency urinary incontinence subdomain,
and (C) total severity domain of the M-ISI questionnaire.
TABLE II. Diagnostic Criteria for Threshold Scores Associated With the SUI
Subdomain, the UUI Subdomain, and the Total M-ISI Domain
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Threshold
score
SUI subdomain 77 73 43 92 3 (out of 12)
UUI subdomain 86 76 73 86 5 (out of 12)
Total M-ISI domain 84 75 75 84 7 (out of 32)
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The Incontinence Screening Questionnaire (ISQ) is an
Australian measure that was developed to determine presence
of incontinence in the general population; however, it was
calibrated to the ‘‘gold standard’’ of 48-hr pad weights, rather
than to patient bother or physician diagnosis.19 While the ISQ
can objectively correlate incontinence with amount of leakage
measured on pads, it lacks an ability to discern incontinence
that is clinically relevant or bothersome to the patient,meaning
it may potentially identify incontinence that does not warrant
treatment.
Finally, the Questionnaire for Urinary Incontinence (QUID)
was developed to classify type of urinary incontinence (stress
versus urgency) in a cohort of women who were seeking care
for urinary incontinence. The QUID had a sensitivity and
specificity of 85% and 71%, comparable to that of the M-ISI.20
However, the QUID was developed in a population of women
that all had urinary incontinence, so its use as a screening tool
to discern whether or not women had urinary incontinence is
not applicable for a more general population of women both
with and without urinary incontinence. M-ISI has the advan-
tage over these measures because it was adapted to determine
the presence of urinary incontinence that is clinically relevant,
and it was developed in a population-based cohort of patients
who were both continent and incontinent, making it an ideal
measure for use as a screening tool for urinary incontinence in
the general population.
While the threshold scores for incontinence and incontinence
subtypes were developed in a large, well characterized
population of community-dwellingwomen, several limitations
should be considered. First, aswith all clinical studies, thiswork
would benefit from external validation in other populations.
Future work is underway to perform this validation in a
population of women presenting for care to their primary care
providers. Second, theM-ISI was introduced to this study cohort
half way through the study period, meaning that not all of the
EPI study participants had the opportunity to complete this
questionnaire. However; once the questionnaire was intro-
duced, it was completed by all participants. Third, while the
sensitivity and specificity for SUI were high, 77% and 73%,
respectively, the positive predictive value for the SUIwas lowat
43% due to the low prevalence of SUI in our cohort (per study
design). Thismay result in referral ofwomenwhoultimately do
not receive treatment; however, this is often the case in the
screening setting.21,22
CONCLUSIONS
This study determined the clinically relevant threshold
scores necessary to use the M-ISI as a screening tool for urinary
incontinence in the general population ages 35–64. The use of
this measure in the primary care setting can identify women
with clinically relevant UI who may benefit from treatment.
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